Background: Direct-to-implant (DTI) and tissue expander/implant (TE/I) reconstructions are the most common implant-based reconstructions after nipple-sparing mastectomy (NSM). However, there are little data beyond complication rates comparing these options. Fat grafting has emerged as an adjunct in NSM reconstructions to improve aesthetic results; however, its impact on patient perceptions of aesthetic outcomes remain unknown. To improve patient-centered care, aesthetic outcomes must be considered from the patients' perspective. Objectives: To evaluate patient-reported outcomes of aesthetic satisfaction and quality of life in patients undergoing immediate DTI vs TE/I reconstruction after NSM and to assess the role of fat grafting on these outcomes. Methods: This is a prospective cohort study comparing NSM patients undergoing DTI or TE/I reconstruction. Patient-reported outcomes were evaluated using the BREAST-Q. Continuous and categorical variables were analyzed using t test and Fisher's exact test, respectively. Results: Fifty-nine patients underwent 113 reconstructions with either DTI (n = 41) or TE/I (n = 18). Mean follow up was 12.1 months. DTI and TE/I patients had comparable satisfaction with outcome, though TE/I patients had significantly larger final implant sizes. TE/I who underwent fat grafting also had significantly higher satisfaction with outcome and psychosocial wellbeing. Conclusions: Patient-reported outcomes are comparable between DTI and TE/I reconstructions after NSM. In order for TE/I patients to achieve a similar level of satisfaction, they may require a larger final implant and additional operations compared to DTI patients. Additionally, fat grafting improves overall satisfaction. TE/I patients may have different aesthetic expectations than DTI patients, emphasizing patient-centered discussions are essential to optimizing outcomes after NSM.
NSM has increased in popularity as both a surgical treatment for breast cancer and a surgical treatment for the prevention of breast cancer (for patients undergoing contralateral or bilateral prophylactic mastectomy). [5] [6] [7] [8] [9] NSM with breast reconstruction is performed as an aesthetic breast reconstruction with the knowledge that nipple sensation or function is not likely to be preserved. 3, 5, 10 Therefore, it could be argued that the main benefit of NSM over other mastectomy techniques is the aesthetic outcome.
Prosthetic breast reconstruction remains the predominant reconstructive method following mastectomy and prosthetic reconstruction after NSM can be performed either in a single-stage direct-to-implant (DTI) reconstruction or 2-stage reconstruction with a tissue expander followed by exchange for a permanent implant prosthesis (TE/I). Proponents of DTI reconstruction emphasize the "breast in a day" concept of a single-stage operation; however, recent studies have demonstrated the average number of operations in DTI reconstruction to often be greater than one. 11 TE/I breast reconstruction will require more planned operations than DTI breast reconstruction because it is a 2-stage, 2-operation procedure by definition. However, in our experience, patients who experience complications in TE/I reconstruction after SSM are likely to require more than 2 operations. 12 With the advent of fat grafting, even patients without complications after SSM are likely to have additional procedures as fat grafting is frequently used as an adjunct procedure to improve the aesthetic result in breast reconstruction. 13 More operations increases the recovery time and healing process for breast cancer patients, but whether more surgery translates to inferior patient-reported outcomes remains unknown. Patients may be willing to undergo more surgery if it leads to a better aesthetic outcome.
Beyond complication profiles, there are limited data comparing DTI and TE/I breast reconstruction after NSM from the patient's perspective using patient-reported outcomes. 11, 14, 15 Furthermore, the impact of fat grafting on patient-reported aesthetic outcomes in implant-based reconstructions after NSM remains unknown. Increasingly, patient-reported outcomes in aesthetic and reconstructive surgery are being used as a way to more clearly depict patients' satisfaction and health-related quality of life. [16] [17] [18] Information about patients' perceptions of aesthetic outcome and satisfaction is integral to promote patient-centered care in breast reconstruction and enable patients to make informed decisions between reconstruction types after NSM.
The objective of this study was to evaluate outcomes in patients undergoing immediate breast reconstruction after NSM using implants and fat grafting, with a specific focus on patient-reported outcomes of aesthetic satisfaction and health-related quality of life. We hypothesized that patient-reported outcomes, including overall satisfaction with outcome, would be higher in DTI breast reconstruction compared to TE/I breast reconstruction because patients would require fewer operations. We also hypothesized that patients who had fat grafting as an adjunct procedure to improve the aesthetic appearance of a reconstructed breast would have higher satisfaction and health-related quality of life on a validated patient-reported outcome instrument (the BREAST-Q).
METHODS

Study Population
This study is a retrospective analysis of patients prospectively enrolled into a study to assess perfusion and patient satisfaction in NSM (NCT01969448: Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy with Immediate Reconstruction). Patients were treated at the Alvin J. Siteman Cancer Center and Washington University School of Medicine in St. Louis from August 2013 to July 2016. A separate institutional review board approval (201608129) was obtained for this cohort study. Demographic and clinical data were abstracted from hospital and clinical records. Two-physician review confirmed the fidelity of data. Patients who underwent DTI reconstruction were compared to those who underwent TE/I reconstruction. All patients had minimum of 6 months follow up from the time of permanent implant placement.
All patients in this study underwent NSM for either breast cancer treatment or prophylaxis. Patients were eligible for inclusion if they were age 18 or older, had a Karnofsky Performance Scale of >80%, were able to provide informed consent, and had either DTI or TE/I reconstruction following NSM. 19 All patients were treated by 2 oncologic surgeons (independent of the study) with experience in NSM techniques and 2 senior plastic surgeons (T.M.M. and M.M.T.) with experience in both DTI and TI/E reconstruction. Patients with concomitant autologous reconstruction were excluded from this analysis. Patients with breast weight greater than 800 grams or less than 100 grams in predicted weight were also excluded from this study. The decision to have either DTI or TE/I breast reconstruction was made by the plastic surgeon based on patient preference, skin flap perfusion and redundancy, and desired volume goals. Patients who were undecided about their volume goals or wanted to have the option to be larger than their existing breast size were essentially planned TE/I reconstructions. TE/I were also used in patients who had ptotic breasts and the surgeon wanted to allow the skin to retract to the size of a smaller device. Conversely, in young women with a tight skin envelope, TE/I were used to expand the skin to allow for a similar or larger size permanent implant. DTI reconstructions were performed in patients who knew preoperatively they wanted to maintain their breast size. If there were concerns about mastectomy flap viability based on intraoperative assessment, a TE/I may have been placed or a smaller permanent implant for a DTI reconstruction. There was little deviation from the plastic surgeon and patient's preoperative plan for DTI vs TE/I, though all patients desiring DTI reconstruction also provided informed consent for TE/I reconstruction.
All tissue expanders were textured Allergan (Allergan, Inc., Dublin, Ireland) 133MV devices. Implants were either Allergan or Sientra (Sientra, Inc., Santa Barbara, CA) devices and included anatomic and round, smooth, and textured implants as these were on consignment at our institution. Implants were all placed in a partial subpectoral plane with the use of acellular dermal matrix (Alloderm RTU, LifeCell Corp., Branchburg, NJ) using nonperforated 8 × 16 cm or 10 × 20 cm sheets for lower pole coverage. Incisions for NSM were either inframammary or lateral radial incisions, and assessment of perfusion and incision placement is an objective of NCT01969448 in which all patients in this study are enrolled. Implant choice was based on discussions between patient and surgeon. Fat harvest was performed using the "super wet" technique with lactated ringers with 15 mL of 1% lidocaine, 1 ampule of 1:1000 epinephrine per liter, and tissue liquefaction technology (TLT; Hydrasolve Lipoplasty System, Andrew Technologies, Irvine, CA). We have previously reported our technique for TLT. 20 The fat grafting donor site was based on physical exam and in all cases was either the abdomen or flank area. Harvested fat was separated using gravity filtration in large sterilized canisters with no centrifugation and injected in 1 cc aliquots into areas of contour irregularity in the superomedial or lateral axillary tail areas.
Patient-reported outcomes were evaluated using the BREAST-Q, a validated instrument specific to breast reconstruction that is designed to measure health-related quality of life and patient satisfaction. 21 Patients completed the preoperative (baseline) BREAST-Q Reconstruction module and a postreconstruction BREAST-Q at 3 months after placement of a permanent implant as a part of the study. All questionnaires were completed electronically using research electronic data capture (REDCap) software. There are different domains including in the BREAST-Q; in this study, patients completed the Satisfaction with Outcome, Satisfaction with Breasts, Psychological Well-Being, Physical Well-Being, and Sexual Well-Being domains. 21, 22 The primary endpoints were patient-reported outcomes as measured by the BREAST-Q Reconstruction modules. All BREAST-Q scores are calculated using the Q-Score software program (New York, NY), and transformed on a scale from 0 to 100; higher scores correlate with better outcomes. 21 We also examined the total number of operative procedures in DTI and TE/I reconstructions, incidence of fat grafting, and volume of fat grafted. Complications were defined as postoperative adverse events requiring an operative intervention and these were assessed from the medical record.
Statistical Analyses
Baseline characteristics in each group (DTI and TE/I) were compared using a two-tailed t test for continuous variables, and Fisher's exact test for categorical variables. Continuous variables are reported as mean ± standard deviation (SD), and categorical variables as a raw number (per cent). A P-value of <0.05 was used to determine significance. BREAST-Q scores were calculated using the Q-Score software program, and raw differences in preoperative and postoperative scores were reported and compared between groups. All statistical tests were performed using SAS 9.4 software system (Cary, NC).
RESULTS
Patient Characteristics
The study population comprised of 59 patients undergoing 113 NSM procedures with immediate breast reconstruction. Patients in this study had a mean age of 44 ± 11 years (DTI, 43 ± 10 years; TE/I, 47 ± 12 years; P = 0.21) and a mean body mass index of 23.5 ± 3.3 kg/m 2 (DTI, 23.4 ± 3.2; TE/I, 23.7 ± 3.7; P = 0.71). Of these, 59 patients, 41 (69.5%) had DTI reconstruction (Supplementary Figure 1) and 18 (30.5%) had TE/I reconstruction (Supplementary Figure 2) . The mean follow up for all patients was 15.2 ± 8.4 months (range, 6.1-35.9 months) for the study population with no difference in follow-up time between study groups (DTI, 14.7 ± 8.3 months; range, 6.1-31 months; TE/I, 16.5 ± 8.8 months; range, 6.8-35.9 months; P = 0.49). All patients with fat grafting had at least 6 months follow up from the time of their fat grafting. Among patients, 93.2% had a permanent anatomic implant while 6.8% had a permanent round implant placed. No patients in the present study were diabetic or active smokers.
Bilateral procedures were performed in 90.2% of DTI and 94.4% of TE/I reconstructions, respectively (P = 1.00). In regards to operative indication, 43.9% of DTI reconstructions were for patients who had prophylactic NSM for cancer prevention while only 11.1% of TE/I patients had bilateral NSM for prophylaxis (P = 0.01). None of the TE/I patients had bilateral cancers. Two TE/I patients had bilateral procedures for prophylaxis while the remainder had a unilateral cancer and contralateral prophylactic mastectomy with TE/I reconstruction. Only one patient had a mastectomy for cancer but did not have a contralateral prophylactic mastectomy. Three DTI patients and one TE/I patient had adjuvant radiation therapy (P = 1.00). One TE/I patient had neoadjuvant chemotherapy. Mastectomy specimen weights did not differ between groups (DTI = 371 ± 166 g vs TE/I = 342 ± 145 g, P = 0.49). Initial fill of the implant at the time of mastectomy and final implant size were different between groups (Table 1) . Fill volumes were significantly lower in the TE/I group when compared to the average permanent implant in the DTI group (P < 0.001), but TE/I reconstructions permanent implants were eventually larger (540 cc vs 454 cc in the DTI group, P < 0.005).
DTI vs TE/I Reconstruction Outcomes and Fat Grafting
The mean number of operative procedures was significantly different between the study cohorts: DTI patients had 1.3 ± 0.5 operative procedures while TE/I patients had 2.3 ± 0.6 operative procedures (P < 0.001). Fat grafting was performed in 24.4% of DTI ( Figure 1 ) and 55.6% of TE/I reconstructions ( Figure 2 ) (P = 0.04). Patients, on average, had 1.0 and 1.1 ± 0.31 rounds of fat grafting in the DTI and TE/I groups, respectively (P = 0.34). The average volume of fat grafted was 104 ± 35 cc and 73 ± 35 cc for DTI and TE/I reconstructions, respectively (P = 0.06).
There were 2 major complications requiring operative intervention and both occurred in the DTI group, resulting in an overall complication rate of 3.39% and a complication rate of 4.88% in the DTI group. Indications for reoperation were for a hematoma and an implant infection requiring an explant.
Patient-Reported Outcomes for DTI vs TE/I Reconstruction
When comparing BREAST-Q Reconstruction scores between DTI (n = 28) and TE/I patients who did not have fat grafting (n = 6), patients with DTI reconstructions, on average, had higher satisfaction with breasts, psychosocial well-being, physical well-being, and sexual well-being, though this did not reach statistical significance (Table 2 ). Taken together, DTI patients had a higher satisfaction with outcome than TE/I reconstructions (80 ± 19 vs 66 ± 12, P = 0.09, Table 2 ).
When comparing numerical average differences between DTI and TE/I patients, the change in satisfaction with breasts were higher for DTI patients (17 ± 19) than TE/I patients (−2 ± 30), however this was not significant (P = 0.05). Changes in psychological well-being were similar (13 ± 23 vs 4 ± 22, P = 0.44) for DTI and TE/I reconstruction, respectively. Physical well-being decreased more in DTI (−6 ± 16) than TE/I patients (−2 ± 23), though this was not significant (P = 0.61). Change in sexual well-being was higher in DTI (13 ± 18) than TE/I patients (−4 ± −34) and was not significantly different (P = 0.27)
The magnitude of changes in satisfaction with breasts, psychosocial well-being, physical well-being, and sexual well-being were all greater in the DTI cohort and must be interpreted to a clinically meaningful endpoint. The BREAST-Q Score Manual classifies changes of 0 to 10 as "little," 10 to 20 as "moderate," and greater than 20 as "very much." 23 Based on this interpretation, patients with DTI reconstructions had moderate changes in their satisfaction with breasts, psychological well-being, and sexual well-being while patients with TE/I implant reconstruction had little changes in these domains. Both TE/I and DTI groups had little changes in physical well-being.
Patient-Reported Outcomes With Fat Grafting
Because DTI patients who underwent fat grafting did so after the 3-month time point at which the postreconstruction BREAST-Q was administered, we were unable to compare patient-reported outcomes by reconstruction type after fat grafting was performed. However, because all patients in the TE/I group had fat grafting at the time of permanent implant exchange, we were able to compare patient-reported outcomes of TE/I patients who did (n = 9) and did not have fat grafting (n = 6). Patients who had TE/I breast reconstruction with fat grafting had significantly higher satisfaction with outcomes (87 ± 17) compared to patients undergoing TE/I reconstruction without fat grafting (66 ± 12, P = 0.02, Table 3 ). Patients who had TE/I reconstruction had similar prereconstruction satisfaction with breast scores regardless if they went on to have fat grafting (TE/I with fat grafting 65 ± 24 vs TE/I without fat grafting 59 ± 16, P = 0.59). Patients who went on to have fat grafting had lower psychological well-being preoperatively than those who did not have fat grafting (63 ± 17 vs 73 ± 12, P = 0.33). Interestingly, patients who would later have fat grafting also had higher physical well-being scores (91 ± 9 vs 81 ± 13, P = 0.1). Sexual well-being was higher in patients who would not go on to have fat grafting (66 ± 19) vs those who did have fat grafting (52 ± 12), though this was not significantly different (P = 0.1). These differences are clinically significant per the BREAST-Q scale, while not statistically significant.
When comparing mean differences between TE/I with fat grafting to TE/I without fat grafting, the satisfaction with breast scores decreased more in patients undergoing TE/I reconstructions with fat grafting (−3 ± 31) than those patients undergoing TE/I reconstructions without fat grafting (−2 ± 31); however this was not significant (P = 0.94). Psychological well-being increased more in TE/I reconstruction with fat grafting than without fat grafting (16 ± 16 vs 5 ± 19, P = 0.21). Physical well-being decreased more in TE/I with fat grafting group (−7 ± 15) than the without fat grafting group (−2 ± 25), though this was not significant (P = 0.68). Additionally, sexual well-being increased more in patients who had fat grafting (7 ± 30) than those who did not have fat grafting (−4 ± 34, P = 0.52).
When interpreting these changes in the setting of clinically meaningful endpoints, patients who had fat grafting with TE/I reconstruction had moderate changes in psychological well-being from their reconstructions while those without fat grafting only had little change. Little change occurred in satisfaction with breasts, physical well-being, and sexual well-being in patients who either had fat grafting or did not have fat grafting after TE/I breast reconstruction. 
DISCUSSION
Immediate implant-based reconstruction after nipple-sparing mastectomy is a popular option for postmastectomy breast reconstruction because it is an aesthetic breast reconstruction that preserves the nipple-areola complex and native skin envelope. 4, 14, 24 Direct-to-implant reconstruction and tissue expander placement followed by exchange for a permanent implant prosthesis are the most common implant-based techniques. However, to date, there is minimal data comparing DTI vs TE/I reconstruction after NSM from the patient's perspective. Prior studies have almost exclusively focused on complication rates associated with these 2 options and did not examine patient-reported outcomes. 11, 14, 15 To our knowledge, this is the first study to compare patient-reported outcomes using a validated instrument, the BREAST-Q, for DTI vs TE/I reconstruction after NSM. The BREAST-Q includes domains related to aesthetic outcomes, specifically the satisfaction with breasts domain considers satisfaction with the overall breast appearance (size, symmetry, softness, implant placement, and cleavage) and scar appearance. 21 We therefore used the BREAST-Q as a tool to study patients' perceptions of the aesthetic outcome and satisfaction with immediate reconstruction after NSM with different implant-based techniques and with autologous fat grafting. Though satisfaction with outcome was higher in DTI patients, it was not significantly different from TE/I patients, indicating that patients have similar overall satisfaction with either implant-based technique following NSM. Our analysis did not find a statistically significant difference between the DTI vs TE/I groups in the numerical BREAST-Q scores of psychological well-being, physical well-being, and sexual well-being; however, we observed a greater, but not statistically significant, improvement in the satisfaction with breasts domain in DTI reconstructions. BREAST-Q scores should be interpreted with clinically relevant meaning as plastic surgeons need to translate patient-reported outcome measures to meaningful conclusions regarding the reconstructive options provided to patients. In this study, patients who had DTI reconstructions had clinically significant, moderate improvements in their satisfaction with breasts, psychological well-being, and sexual well-being. TE/I reconstruction patients only had little changes in these domains. Both groups had little changes in physical well-being suggesting the morbidity of subpectoral permanent implant placement is no different than placement of a tissue expander and subsequent expansion.
Patients in our study who had TE/I reconstructions had a larger final implant placed at the time of implant exchange, despite the fact that mastectomy specimen weights did not differ by study group. This suggests that TE/I reconstruction may afford an opportunity for the patient and physician to "augment" the breast and expand the breast envelope to a size larger than the patient was before mastectomy or may be able to achieve with a DTI reconstruction. On average, the final implant in a TE/I reconstruction was 20% larger than those used in DTI reconstructions. From clinical experience it is known that the skin envelope and perfusion can limit the size of the implant that can be placed. Interestingly, despite having larger permanent implants, patients with TE/I reconstruction had a lower satisfaction with outcome, though this was not statistically significant, and little changes in all BREAST-Q domains suggesting that final implant size may not necessarily predict higher patient satisfaction in breast reconstruction. This parallels data from the breast augmentation literature demonstrating implant volume is not associated with higher postoperative satisfaction with breasts. 25 Though patient-reported outcomes were comparable in this study between the 2 cohorts, patients undergoing TE/I reconstruction may have different expectations and may require a larger, "augmented" breast to achieve similar satisfaction with the aesthetic outcome.
One hypothesized advantage to DTI reconstruction is the need for fewer overall operations. This is especially true after NSM as preservation of the nipple-areola complex, while doing little to preserve nipple sensitivity, avoids the need for further operations to reconstruct the nipple. 4, 24 By definition, TE/I reconstruction is at least a 2-stage, two operation reconstruction following a skin-sparing or nipple-sparing mastectomy, and the outcome pathways can change if complications occur. 12 Alternatively, DTI reconstruction is appealing for being a single-stage or "breast in a day" immediate reconstruction. 11 In our study, over a quarter of DTI and over half of TE/I reconstruction patients had autologous fat grafting to improve the overall aesthetic outcome. While both anatomic and round implants were used, fat grafting was used as a way to improve superomedial fullness and improve the transitions in contour between chest wall and implant to create a more natural, aesthetic contour to the breast. In our experience, TE/I reconstruction patients were more likely to undergo fat grafting than DTI patients, a finding that was statistically significant. It is possible that TE/I patients had higher aesthetic demands and expectations, wanted a larger implant, and/or also expected a more natural appearing breast than DTI patients who may have wanted a more simple, single operation reconstruction. There also may be a lower threshold to fat graft TE/I patients at the time of implant exchange because these patients are already committed to a second operation for tissue expander exchange for a permanent implant. In our experience, however, fat grafting was done in DTI or TE/I reconstructions only if it was felt to improve the aesthetic outcome and correct contour irregularities that were bothersome to the patient. Though our follow-up time does not differ between DTI and TE/I patients, it is possible that DTI patients who during the study period did not undergo fat grafting may eventually go on to have fat grafting because of changes in contour or aging of the breast, Longitudinal studies of these groups will be better able to examine the reconstructive pathways of DTI and TE/I patients. Additionally, our number of operations closely matches published data on DTI reconstruction after NSM. 11 As expected, TE/I reconstruction required exactly one more operation on average than DTI reconstruction. TE/I patients may have been more willing to undergo a longer reconstructive journey for the option of a larger final implant; however, our existing data do not allow us to explore specific patient reasons for decision-making or patient expectations and this should be a focus of future studies on the topic. Patients who had fat grafting, on average, had a single round of fat grafting with average volumes that were not significantly different in DTI vs TE/I reconstructions. In TE/I patients, this was done at the time of permanent implant exchange. While there are concerns about the longevity of fat grafting and need for multiple rounds of fat grafting, our study did not find that one reconstruction required more rounds of fat grafting than the other. Our conclusions about longevity of fat grafting are limited to the fact that all patients who had fat grafting could have had as little as 6 months follow up after fat grafting; however, patients on average were followed for 15 months in this study. When looking at our overall cohort, a single round of fat grafting either at the time of implant exchange in TE/I reconstruction or as a separate adjunct procedure for DTI patients sufficed. Further studies specifically looking at the longevity of fat grafting in nipple sparing mastectomies are warranted. The use of fat grafting for select patients in implant-based reconstruction after NSM parallels the experience for select patients undergoing breast augmentation, where the lack of adequate breast tissue to cover an implant in augmentation is compensated with fat grafting. 26, 27 Fat grafting in our cohort differs from composite breast augmentation in that no fat grafting was done in DTI patients at the time of implant placement.
In order to examine the effects of fat grafting on patient-reported outcomes and perceptions of aesthetic outcome, our analysis was limited to TE/I patients only as the BREAST-Q was administered at the 3-month postpermanent implant placement time point and patients with DTI reconstruction typically had fat grafting after this time point. Our analysis of the impact of fat grafting in NSM reconstruction is therefore limited to patients who had TE/I reconstruction. Patients with TE/I reconstruction who had fat grafting had a statistically significant greater satisfaction with their outcome. They also experienced moderate increases in their psychological well-being. The improvement in psychological well-being may be attributable to fat harvested from an area of extra adiposity, resulting in a combined benefit from the fat grafting with regards to body contour and improvement in breast appearance. This would parallel possible perceived improvements in body image in patients who have autologous breast reconstruction with abdominal tissue and subsequently have improved abdominal contour in addition to a reconstructed breast. 28, 29 While the strengths of our study include the prospective design and emphasis on patient-reported outcomes, our study does have some limitations that merit discussion. For one, our data does not allow us to analyze patients' motivations to undergo DTI vs TE/I breast reconstruction, potentially representing a selection bias. The decision on which type of implant-based reconstruction to have is made by the patient after discussing all potential options with their surgeon, as is standard practice at most centers. To date, there are limited data to help patients and physicians decide between reconstructive options following NSM. While 43.9% of DTI patients had prophylactic surgery, only 11% of TE/I had prophylactic surgery. While this difference is significant, we did not favor TE/I reconstruction in patients with cancer for oncologic reasons, such as possible need for radiation as radiation exposure did not differ by reconstruction type in our study. Our study does not specifically examine differences in the psychological profile of patients with cancer vs those who undergo reconstruction for prophylaxis in nipple sparing mastectomies, though this has been explored elsewhere in a limited fashion. 33, 34 In our experience, the decision on reconstruction type must be made taking into account numerous factors, including a patients' anatomy and ideal breast size, patients' goals, willingness to have a prosthetic reconstruction, and understanding of possibly requiring more than one operation. It can also be impacted by intraoperative factors such as perfusion to the mastectomy flaps. If there was concern about mastectomy flap viability, which could include a more aggressive mastectomy on a cancerous breast, a TE/I could be placed unless the patient was willing to have a smaller breast and desired a DTI reconstruction. Ptotic breasts may have more skin to perfuse and therefore may need an expander because the mastectomy flaps may not be adequately perfused for a permanent implant. However, ptotic breasts also translate to a more lax skin envelope, which would mean the breast oncologic surgeon might have an easier time performing the mastectomy with less traction injury from retractors.
Our experience suggests that DTI and TE/I are indeed different sets of patients with different anatomy and aesthetic expectations, which can be elucidated preoperatively. This information and an understanding of expectations is useful to the plastic surgeon who must also consider intraoperative factors that can only be known once the mastectomy is complete. In our experience, there was rare deviation from preoperative plans discussed with patients after understanding their anatomy and aesthetic expectations to perform a DTI or TE/I reconstruction.
Our evaluation of patient-reported outcomes are limited to the 3-month postoperative period. While this is standard for most studies evaluating patient-reported outcomes using the BREAST-Q, there are data to suggest health-related quality of life and satisfaction evolves over time. [30] [31] [32] Additional studies evaluating long-term patient-reported outcomes with different implant-based techniques are necessary to characterize changes in satisfaction over time. An additional limitation is that we were unable to directly compare patient-reported outcomes after fat grafting between the DTI cohort and the TE/I cohort. Further studies that directly compare DTI reconstruction with and without fat grafting and DTI reconstruction with fat grafting to TE/I reconstruction with fat grafting can further examine the impact of reconstruction type and fat grafting on health-related quality of life and satisfaction outcomes. Implant choice was not standardized in the study as implants were chosen after discussing risks, benefits, and alteratives of different implants available on consignment at our institution. Finally, our study, by design, did not include surgeon appraisal of aesthetic outcome, but rather focused on patients' perceptions of outcomes.
This study expands on the current literature to provide data on patient-reported outcomes for the 2 most common types of implant-based breast reconstruction techniques after NSM. Our study is the first of its kind to evaluate patient-reported outcomes specifically in DTI and TE/I reconstructions following NSM and furthers the ability of providers to engage in patient-centered care discussions about breast reconstruction. It also provides a better understanding of differences in the aesthetic expectations of DTI and TE/I patients.
CONCLUSIONS
Immediate breast reconstruction with DTI or TE/I techniques after NSM is truly an aesthetic breast reconstruction. While there is a trend towards higher patient-reported outcomes in DTI reconstruction, TE/I patients may be willing to undergo more surgeries for a larger, "augmented" breast at the time of implant exchange. These patients may have different aesthetic expectations for their reconstructed breast than DTI patients. Fat grafting in patients who have TE/I reconstruction have significantly higher satisfaction with outcome suggesting fat grafting can be used to improve the patients' satisfaction with the aesthetic outcome of a reconstructed breast after NSM.
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